Skip to main content
Log in

Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity

  • Organ Toxicity and Mechanisms
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The kinetic analysis of esterase inhibition by acylating compounds (organophosphorus carbamates and sulfonyl fluorides) is sometimes unable to yield consistent results by fitting simple inhibition kinetic models to experimental data of complex systems. In this work, kinetic data were obtained for phenylmethylsulfonyl fluoride (PMSF) tested at different concentrations incubated for up to 3 h with soluble fraction of chicken peripheral nerve. PMSF is a protease and esterase inhibitor causing protection or potentiation of the organophosphorus-induced delayed neuropathy and is unstable in water solution. The target of the promotion effect was proposed to be a soluble esterase not yet identified. A kinetic model equation was deduced assuming a multienzymatic system with three different molecular phenomena occurring simultaneously: (1) inhibition, (2) spontaneous chemical hydrolysis of the inhibitor and (3) ongoing inhibition (inhibition during the substrate reaction). A three-dimensional fit of the model was applied for analyzing the experimental data. The best-fitting model is compatible with a resistant component (16.5–18%) and two sensitive enzymatic entities (both 41%). The corresponding second-order rate constants of inhibition (ki = 12.04 × 10−2 and 0.54 × 10−2 μM−1 min−1, respectively) and the chemical hydrolysis constant of PMSF (kh = 0.0919 min−1) were simultaneously estimated. These parameters were similar to those deduced in fixed-time inhibition experiments. The consistency of results in both experiments was considered an internal validation of the methodology. The results were also consistent with a significant ongoing inhibition. The proportion of enzymatic components showed in this work is similar to those previously observed in inhibition experiments with mipafox, S9B and paraoxon, demonstrating that this kinetic approach gives consistent results in complex enzymatic systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Aldridge WN, Reiner E (1972) Enzyme inhibitors as substrates. North-Holland, Amsterdam

    Google Scholar 

  • Barril J, Vilanova E (1997) Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase. Chem Biol Interact 108:19–25

    Article  PubMed  CAS  Google Scholar 

  • Barril J, Estévez J, Escudero MA, Céspedes MV, Ñíguez N, Sogorb MA, Monroy A, Vilanova E (1999) Peripheral nerve soluble esterases are spontaneously reactivated after inhibition by paraoxon: implication for a new definition of neuropathy target esterase. Chem Biol Interact 119–120:541–550

    Article  PubMed  Google Scholar 

  • Bazire A, Gillon E, Lockridge O, Vallet V, Nachon F (2011) The kinetic study of the inhibition of human cholinesterases by demeton-S-methyl shows that cholinesterase-based titration methods are not suitable for this organophosphate. Toxicol In Vitro 25(3):754–759

    Article  PubMed  CAS  Google Scholar 

  • Carrera V, Barril J, Mauricio M, Pellín M, Vilanova E (1992) Local application of neuropathic organophosphorus compounds to hen sciatic nerve: inhibition of neuropathy target esterase and peripheral neurological impairments. Toxicol Appl Pharmacol 117(2):218–225

    Article  PubMed  CAS  Google Scholar 

  • Escudero MA, Céspedes MV, Vilanova E (1997) Chromatographic discrimination of soluble neuropathy target esterase isoenzymes and related phenyl valerate esterases from chicken brain, spinal cord, and sciatic nerve. J Neurochem 68(5):2170–2176

    Article  PubMed  CAS  Google Scholar 

  • Estévez J, Vilanova E (2009) Model equations for the kinetics of covalent irreversible enzyme inhibition and spontaneous reactivation: esterases and organophosphorus compounds. Crit Rev Toxicol 39(5):427–448

    Article  PubMed  Google Scholar 

  • Estévez J, García-Pérez AG, Barril J, Pellín M, Vilanova E (2004) The inhibition of the high sensitive peripheral nerve soluble esterases by mipafox: a new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds. Toxicol Lett 151:171–181

    Article  PubMed  Google Scholar 

  • Estévez J, Barril J, Vilanova E (2010) Inhibition with spontaneous reactivation and the “ongoing inhibition” effect of esterases by biotinylated organophosphorus compounds: S9B as a model. Chem Biol Interact 187:397–402

    Article  PubMed  Google Scholar 

  • Estévez J, García-Pérez A, Barril J, Vilanova E (2011) Inhibition with spontaneous reactivation of carboxyl esterases by organophosphorus compounds: paraoxon as a model. Chem Res Toxicol 24:135–143

    Article  PubMed  Google Scholar 

  • Eyer P, Radtke M, Worek F (2008) Reactions of isodimethoate with human red cell acetylcholinesterase. Biochem Pharmacol 75:2045–2053

    Article  PubMed  CAS  Google Scholar 

  • Gambalunga A, Pasqualato F, Lotti M (2010) Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy. Chem Biol Interact 187:340–343

    Article  PubMed  CAS  Google Scholar 

  • Glynn P, Read DJ, Guo R, Wylie S, Johnson MK (1994) Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. Biochem J 301:551–556

    PubMed  CAS  Google Scholar 

  • Glynn P, Read DJ, Lush MJ, Li Y, Atkins J (1999) Molecular cloning of neuropathy target esterase (NTE). Chem Biol Interact 119–120:513–517

    Article  PubMed  Google Scholar 

  • James GT (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal Biochem 86(2):574–579

    Article  PubMed  CAS  Google Scholar 

  • Johnson MK (1969) The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem J 114:711–717

    PubMed  CAS  Google Scholar 

  • Johnson MK (1977) Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 37:113–115

    Article  PubMed  CAS  Google Scholar 

  • Johnson MK (1982) The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev Biochem Toxicol 4:141–212

    CAS  Google Scholar 

  • Johnson MK (1987) Receptor or enzyme: the puzzle of NTE and organophosphorus-induced delayed polyneuropathy target esterase of hen brain. Trends Pharmacol Sci 8:174–179

    Article  CAS  Google Scholar 

  • Kropp TJ, Glynn P, Richardson RJ (2004) The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 43(12):3716–3722

    Article  PubMed  CAS  Google Scholar 

  • Lotti M, Caroldi S, Capodicasa E, Moretto A (1991) Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol Appl Pharmacol 108:234–241

    Article  PubMed  CAS  Google Scholar 

  • Lush MJ, Li Y, Read DJ, Willis AC, Glynn P (1998) Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J 15, 332 (Pt 1):1–4

    Google Scholar 

  • Milatovic D, Moretto A, Osman KA, Lotti M (1997) Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Chem Res Toxicol 10:1045–1048

    Article  PubMed  CAS  Google Scholar 

  • Moretto A (2000) Promoters and promotion of axonopaties. Toxicol Lett 112(113):17–21

    Article  PubMed  Google Scholar 

  • Moretto A, Gardiman G, Panfilo S, Colle MA, Lock EA, Lotti M (2001) Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy. Toxicol Sci 62(2):274–279

    Article  PubMed  CAS  Google Scholar 

  • Pope CN, Padilla S (1990) Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol Environ Health 31:261–273

    Article  PubMed  CAS  Google Scholar 

  • Williams DG, Johnson MK (1981) Gel electrophoretic identification of hen brain neurotoxic esterase labeled with tritiated diisopropylphosphofluridate. Biochem J 199(2):323–333

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge Estévez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Estévez, J., Barril, J. & Vilanova, E. Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity. Arch Toxicol 86, 767–777 (2012). https://doi.org/10.1007/s00204-012-0817-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-012-0817-3

Keywords

Navigation